Implementation of AI-driven support for ovarian cancer ultrasound diagnosis
| Reference number | |
| Coordinator | Intelligyn AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | January 2025 - December 2025 |
| Status | Ongoing |
| Venture | Global cooperation 2024 |
| Call | Planning grant for international proposal 2024 |
Purpose and goal
Intelligyn has developed an AI-powered decision support for ultrasound diagnosis of ovarian tumors. Our large validation study (nature medicine) has shown excellent results. Clinical regulatory studies are ongoing at Södersjukhuset, in collaboration with KI, Intelligyn and GE Healthcare. The purpose of this proposal is to strengthen our chances of receiving money from EIC Accelerator long proposal by performing market analyses, freedom to operate analysis and refining our business model.
Expected effects and result
We expect that the grant will improve our chances of a successful proposal EIC Accelerator-ansökan, by refining our business plan and go to market strategy, based on customer feedback from ongoing clinical studies, and market analysis. The support will also help us perform a freedom to operate analysis and improve our data management plan.
Planned approach and implementation
We are planning five main activities, 1) Market analysis in the Nordics and selected countries in Europe 2) Refined business plan based on analysis of customer feedback 3) Coaching to write the long EIC proposal, as our short proposal was accepted with good feedback (4/4 Go) 4) Get consultant help to perform a ´freedom to operate analysis´ 5) Coaching to improve our data management plan